Pfizer Stock News

2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist

2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab (“Zai Lab”, NASDAQ: ZLAB; HKEX: 9688) and Pfizer (“Pfizer”, NYSE: PFE) announced today a strategic collaboration for the novel antibacterial drug XACDURO® (sulbactam-durlobactam) in mainland China. Pfizer's affiliated companies will be exclusively authorized to undertake and perform certain commercialization activities for XACDURO® in mainla...

The appetite for high-risk investments really increased following Donald Trump's presidential victory.

Last year, the S&P 500 reached new highs despite geopolitical tensions and market pressures.

The drug company had been searching for a new chief scientific officer since July with Mikael Dolsten leaving after 15 years at the company.

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff, M.D., PhD, as Chief Scientific Officer and President, Research & Development effective January 1, 2025. Dr. Boshoff, who most recently served as Chief Oncology Officer and Executive Vice President, will succeed Dr. Mikael...

Pfizer has named company veteran Chris Boshoff, who led the drugmaker's cancer research and marketing for more than a year, as its R&D chief, WSJ reported on Wednesday.